Mark Cooper

494 total citations
16 papers, 384 citations indexed

About

Mark Cooper is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Mark Cooper has authored 16 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Immunology. Recurrent topics in Mark Cooper's work include Signaling Pathways in Disease (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and HIV Research and Treatment (2 papers). Mark Cooper is often cited by papers focused on Signaling Pathways in Disease (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and HIV Research and Treatment (2 papers). Mark Cooper collaborates with scholars based in United States and United Kingdom. Mark Cooper's co-authors include Thomas E. Starzl, Andreas G. Tzakis, John W. Ward, J. S. Dummer, Margaret V. Ragni, John J. Fung, Nick L. Occleston, Hugh Laverty, Michael A. Nalesnik and Tracey Mason and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and Wound Repair and Regeneration.

In The Last Decade

Mark Cooper

15 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Cooper United States	8	120	104	74	74	66	16	384
H T Cook United Kingdom	10	92 0.8×	78 0.8×	131 1.8×	110 1.5×	25 0.4×	16	379
Gil Cunha De Santis Brazil	15	43 0.4×	127 1.2×	88 1.2×	8 0.1×	60 0.9×	51	654
Christoffer Dellgren Denmark	6	102 0.8×	40 0.4×	17 0.2×	6 0.1×	89 1.3×	11	555
Alberto Torı́o Spain	14	94 0.8×	7 0.1×	161 2.2×	203 2.7×	26 0.4×	39	541
Donald S. David United States	7	91 0.8×	20 0.2×	112 1.5×	17 0.2×	72 1.1×	11	366
F. Smets Belgium	12	168 1.4×	67 0.6×	220 3.0×	44 0.6×	241 3.7×	22	585
Miguel Forte Italy	9	80 0.7×	53 0.5×	43 0.6×	10 0.1×	104 1.6×	20	490
Myriam Libin Belgium	9	90 0.8×	68 0.7×	85 1.1×	32 0.4×	46 0.7×	11	373
Marcia M. L. Kho Netherlands	15	115 1.0×	66 0.6×	140 1.9×	293 4.0×	84 1.3×	44	566
Dominique Masson France	12	57 0.5×	50 0.5×	82 1.1×	156 2.1×	51 0.8×	49	470

Countries citing papers authored by Mark Cooper

Since Specialization

Citations

This map shows the geographic impact of Mark Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cooper more than expected).

Fields of papers citing papers by Mark Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cooper. The network helps show where Mark Cooper may publish in the future.

Co-authorship network of co-authors of Mark Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Cooper. A scholar is included among the top collaborators of Mark Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Cooper. Mark Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Weaver, Andrew J., et al.. (2021). Recurrent Spontaneous Pneumothorax During Pregnancy; A Case Report. SHILAP Revista de lepidopterología. 7(2). 10–10.

Occleston, Nick L., Sharon O’Kane, Hugh Laverty, et al.. (2011). Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring. Wound Repair and Regeneration. 19(s1). s38–48. 68 indexed citations

Gurk‐Turner, Cheryle, David K. Klassen, Mark Cooper, et al.. (2008). SUCCESSFUL ALEMTUZUMAB INDUCTION AND STEROID WITHDRAWAL IN AFRICAN AMERICAN AND CAUCASIAN RECIPIENTS OF RENAL TRANSPLANTS. Transplantation. 86(2S). 651–651. 1 indexed citations

Orchard, Kim & Mark Cooper. (2004). Targeting the bone marrow: applications in stem cell transplantation.. PubMed. 48(4). 267–78. 4 indexed citations

Cooper, Mark, Stephen H. Gregory, Thomas E. Starzl, & Edward J. Wing. (1994). RAPAMYCIN BUT NOT FK506 INHIBITS THE PROLIFERATION OF MONONUCLEAR PHAGOCYTES INDUCED BY COLONY-STIMULATING FACTORS. Transplantation. 57(3). 433–439. 15 indexed citations

Cooper, Mark, et al.. (1993). CROSS-SPECIES GRAFT-VERSUS-HOST-DISEASE IS ACCOMPANIED BY A DONOR-DERIVED CELLULAR. Transplantation. 56(4). 934–940. 3 indexed citations

Nalesnik, M, Joseph Locker, Ronald Jaffe, et al.. (1992). Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clinical Transplantation. 6(3pt2). 249–252. 26 indexed citations

Nalesnik, Michael A., Joseph Locker, Ronald Jaffe, et al.. (1992). Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients.. PubMed. 6(Spec). 249–252. 34 indexed citations

Cooper, Mark, P. M. Markus, Xin Cai, TE Starzl, & John J. Fung. (1991). Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.. PubMed. 23(6). 3238–9. 6 indexed citations

10.

Cooper, Mark, et al.. (1991). Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.. PubMed. 23(6). 2957–8. 4 indexed citations

11.

Boggs, S S, K. D. Patrene, P. M. Markus, et al.. (1991). FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice.. PubMed. 23(6). 3236–7. 2 indexed citations

12.

Cooper, Mark, Grace Hartman, Thomas E. Starzl, & John J. Fung. (1991). The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506.. PubMed. 23(6). 3234–5. 16 indexed citations

13.

Reyes, Jorge, Andreas G. Tzakis, M. Green, et al.. (1991). Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.. PubMed. 23(6). 3044–6. 38 indexed citations

14.

Markus, P. M., Gennaro Selvaggi, Mark Cooper, et al.. (1991). The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.. PubMed. 23(6). 3232–3. 6 indexed citations

15.

Tzakis, Andreas G., Mark Cooper, J. S. Dummer, et al.. (1990). TRANSPLANTATION IN HIV+ PATIENTS. Transplantation. 49(2). 354–358. 138 indexed citations

16.

Cooper, Mark. (1967). Prices and Profits in the Pharmaceutical Industry. BMJ. 2(5544). 109.3–109. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact